| September 6, 2006 |
| August 22, 2008 |
| January 2007 |
| January 2008 (final data collection date for primary outcome measure) |
| Survival to discharge from hospital |
| Same as current |
| Complete list of historical versions of study NCT00373763 on ClinicalTrials.gov Archive Site |
- Maternal morbidity
- Fetal morbidity
- Premature preterm rupture of membranes
- Unintended preterm delivery
- Conventional ventilation strategies possible
- ECMO required
- Days in intensive care
- Days in hospital
- Oxygen dependency on discharge
|
| Same as current |
| |
| Fetoscopic Tracheal Balloon Occlusion in Unborns With Severe Congenital Diaphragmatic Hernia - EUROTRIAL I |
| Randomized Clinical Trial for the Assessment of the Life-Saving Potential of Fetoscopic Tracheal Balloon Occlusion in Fetuses With Severe Congenital Diaphragmatic Hernia - EUROTRIAL I |
Diaphragmatic hernia detected in fetal life carries a high risk for postnatal demise due to lung underdevelopment. Clinical experience from prospective controlled non-randomized case series with fetoscopic tracheal balloon occlusion has seen improved survival rates in contrast to untreated controls. Therefore, the purpose of this randomized clinical trial is to provide further evidence about the efficacy and safety of the prenatal interventional approach. Primary outcome measure is postnatal survival to discharge from hospital treatment. |
| |
| |
| Interventional |
| Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study |
| Diaphragmatic Hernia |
| Procedure: Fetoscopic tracheal balloon occlusion |
| |
| Kohl T, Gembruch U, Filsinger B, Hering R, Bruhn J, Tchatcheva K, Aryee S, Franz A, Heep A, Muller A, Bartmann P, Loff S, Hosie S, Neff W, Schaible T; German Center for Fetal Surgery Diaphragmatic Hernia Task Group. Encouraging early clinical experience with deliberately delayed temporary fetoscopic tracheal occlusion for the prenatal treatment of life-threatening right and left congenital diaphragmatic hernias. Fetal Diagn Ther. 2006;21(3):314-8. |
| |
| Withdrawn |
| 98 |
|
| January 2008 (final data collection date for primary outcome measure) |
Inclusion Criteria:
- Pregnant women from European countries carrying fetuses with congenital right or left diaphragmatic hernias
- Normal karyotype, no further severe anomalies on prenatal ultrasound study
- Fetal liver herniation into the chest, Lung-to-head ratio of ≥0,40 ≤0,84 between 30+0 - 33+5 weeks+days of gestation
Exclusion Criteria:
- Any maternal disease or condition that would result in an increased risk to her personal health from the experimental procedure
- Abnormal fetal karyotype
- Further severe fetal anomalies on prenatal ultrasound
|
| Female |
| 18 Years to 50 Years |
| Yes |
| Contact information is only displayed when the study is recruiting subjects |
| Germany |
| |
| NCT00373763 |
| Thomas Kohl MD, German Center for Fetal Surgery & Minimally-Invasive Therapy |
| DH-EUROTRIAL I - 093/06, 093/06 |
| University Hospital, Bonn |
| University Hospital Mannheim |
| Principal Investigator: |
Thomas Kohl, MD |
German Center for Fetal Surgery & Minimally-Invasive Therapy, University of Bonn, Germany |
|
| Principal Investigator: |
Thomas Schaible, MD |
Neonatal Intensive Care Unit (ECMO center), University of Mannheim, Germany |
|
|
| University Hospital, Bonn |
| August 2008 |